RTI Surgical launches Tritium Sternal Cable Plating for open heart procedures

11 August 2013 (Last Updated August 11th, 2013 18:30)

RTI Surgical, a US-based global surgical implant firm, has launched Tritium Sternal Cable Plating (SCP), a system designed for the closure of median sternotomies following open-heart surgeries.

RTI Surgical, a US-based global surgical implant firm, has launched Tritium Sternal Cable Plating (SCP), a system designed for the closure of median sternotomies following open-heart surgeries.

The system received US FDA clearance in October 2012 and was first clinically used in January this year.

Tritium Sternal Cable Plating lends stability and strength to the conventional sternal closure method by employing a load-sharing concept.

Combining the benefits of cerclage cables and cancellous screws and integrated with a plate of low profile nature, the device creates a load-sharing design that employs cable tension to offer circumferential compression across the median sternotomy.

RTI Surgical CEO and president Brian K. Hutchison noted that the Tritium SCP System is the first implant launched since the acquisition of Pioneer Surgical Technology.

"The system received US FDA clearance in October 2012 and was first clinically used in January this year."

"This system is one of many exciting products RTI Surgical is launching this year and we are extremely pleased with the surgeon feedback we have seen so far," Hutchinson added.

Michigan-located Henry Ford Macomb Hospital cardiothoracic surgery unit medical director Dr. Steven D Harrington noted that the end result on using it was a solid, tight sternal closure with a plating system that did not require extra dissection or devascularisation of the sternum to achieve fixation and screw placement.

"I have found the Tritium cable plate system to be one of the most secure and easy to use closure systems available," added Dr Harrington.

The Tritium cable plate system offers extra measure of stable approximation while being simple and straightforward to size and implant.

Based in Florida, RTI has four manufacturing facilities across the US and Europe and its devices are distributed in over 47 countries.